Cognyte Software Ltd. (CGNT)
9.52
-0.18 (-1.86%)
At close: Apr 17, 2025, 3:59 PM
9.75
2.42%
After-hours: Apr 17, 2025, 06:49 PM EDT
Cognyte Software Revenue Breakdown
| Period Ending | Dec 31, 2017 | Jun 30, 2013 | Mar 31, 2013 | Dec 31, 2012 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|
| Airway Management Revenue | 3.28M | 623K | 760K | 982K | 1.01M | 900K |
| Airway Management Revenue Growth | +426.00% | -18.03% | -22.61% | -3.25% | +12.78% | n/a |
| Industrial Revenue | 3.73M | n/a | n/a | n/a | n/a | n/a |
| Industrial Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
| Urology Revenue | 49.31M | n/a | n/a | n/a | n/a | n/a |
| Urology Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jan 31, 2024 | Jan 31, 2023 | Jan 31, 2022 | Jan 31, 2021 | Mar 31, 2014 |
|---|---|---|---|---|---|
| Americas Revenue | 17.18M | 45.13M | 55.59M | 51.88M | 11.44M |
| Americas Revenue Growth | -61.94% | -18.83% | +7.16% | +353.69% | n/a |
| Asia Pacific Revenue | 12.49M | 7.63M | 12.69M | 11.9M | n/a |
| Asia Pacific Revenue Growth | +63.58% | -39.86% | +6.61% | n/a | n/a |
| Emea Revenue | 283.74M | 259.3M | 405.76M | 379.67M | n/a |
| Emea Revenue Growth | +9.42% | -36.09% | +6.87% | n/a | n/a |
| Germany Revenue | 53.48M | 44.49M | 63.26M | 86.83M | n/a |
| Germany Revenue Growth | +20.22% | -29.68% | -27.15% | n/a | n/a |
| Israel Revenue | 215.31M | 201.61M | 328.37M | 274.11M | n/a |
| Israel Revenue Growth | +6.80% | -38.60% | +19.79% | n/a | n/a |
| Other Americas Region Revenue | 7.15M | 9.99M | 17.87M | 7.13M | n/a |
| Other Americas Region Revenue Growth | -28.44% | -44.11% | +150.48% | n/a | n/a |
| Other Emea Region Revenue | 14.95M | 13.21M | 14.13M | 18.73M | n/a |
| Other Emea Region Revenue Growth | +13.19% | -6.51% | -24.56% | n/a | n/a |
| United States Revenue | 10.03M | 35.14M | 37.73M | 44.75M | n/a |
| United States Revenue Growth | -71.46% | -6.86% | -15.69% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | Apr 30, 2021 | Jan 31, 2021 | Oct 31, 2020 | Jul 31, 2020 | Apr 30, 2020 | Jan 31, 2020 | Oct 31, 2019 | Jul 31, 2019 | Apr 30, 2019 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 36.76M | 34.76M | 30.56M | 33.3M | 32.62M | 31.31M | 28.8M | 35.07M | 36.83M | 39.04M | 43.4M | 46.85M | 43.06M | 45.14M | 50.82M | 49.36M | 40.21M | 32.73M | 40.29M | 42.75M | 42.75M | 36.75M | 36.75M | 31.2B | 2.06M | 2.06M | 2.14M | 346.52K |
| Selling, General, and Administrative Revenue Growth | +5.76% | +13.74% | -8.23% | +2.09% | +4.19% | +8.72% | -17.89% | -4.76% | -5.67% | -10.04% | -7.36% | +8.80% | -4.61% | -11.17% | +2.95% | +22.76% | +22.84% | -18.75% | -5.76% | 0.00% | +16.34% | 0.00% | -99.88% | +1517343.00% | -0.12% | -3.64% | +516.46% | n/a |
| Research and Development Revenue | 27.19M | 26.18M | 26.78M | 27.04M | 25.4M | 27.1M | 27.75M | 30.67M | 33.13M | 38.55M | 37.98M | 38.29M | 35.53M | 36.13M | 33.41M | 36.53M | 31.92M | 29.07M | 31.19M | 31.23M | 31.23M | 27.34M | 27.34M | 4.74B | 1.23M | 1.03M | 1.29M | 1.39M |
| Research and Development Revenue Growth | +3.87% | -2.24% | -0.94% | +6.45% | -6.29% | -2.32% | -9.53% | -7.43% | -14.06% | +1.50% | -0.81% | +7.78% | -1.67% | +8.13% | -8.53% | +14.43% | +9.81% | -6.80% | -0.12% | 0.00% | +14.23% | 0.00% | -99.42% | +383769.90% | +19.64% | -20.05% | -6.89% | n/a |